FGFR3 and osteosarcoma: Together, these integrative single-cell computational analyses provide evidence that p53 loss in Fgfr3+ endosteal stromal cells leads to osteosarcoma-like lesions associated with genomic instability and intratumoral heterogeneity, which share strong transcriptional similarity with chondroblastic osteosarcoma in humans.